GlassScriptPhysician profile
Jennifer Byer
NPI 1336438522
$19,014.70
in general payments reported to CMS, 2019-2025
83 companies · $2,300 in 2025
The $2,300 reported for 2025 was more than what a typical Medical Oncology provider received nationally (typical 2025 total: $1,158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,749 · 2020: $2,587 · 2021: $3,227 · 2022: $3,638 · 2023: $2,915 · 2024: $1,599 · 2025: $2,300.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,797 · Education: $17.16.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,797.37 |
| Education | $17.16 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $1,501.39 | 2019-2025 | |
| E.R. Squibb & Sons, L.L.C. | $1,272.97 | 2019-2025 | Opdivo, Krazati, Opdualag |
| Janssen Biotech, INC. | $1,215.56 | 2019-2025 | Erleada, Tecvayli, Akeega |
| Pfizer INC. | $1,165.62 | 2019-2025 | |
| Astrazeneca Pharmaceuticals LP | $1,056.33 | 2019-2025 | Enhertu, Imfinzi |
| Celgene Corporation | $1,018.25 | 2019-2025 | Reblozyl, Pomalyst, Opdualag |
| Merck Sharp & Dohme LLC | $905.42 | 2019-2025 | Keytruda, Lynparza, Welireg |
| Glaxosmithkline, LLC. | $819.12 | 2020-2025 | Ojjaara, Zejula, Jemperli |
| Amgen INC. | $692.16 | 2019-2023 | Nplate, Xgeva, Lumakras |
| Seagen INC. | $620.62 | 2019-2023 | Adcetris, Tivdak, Padcev |
| Genzyme Corporation | $604.43 | 2019-2025 | |
| Daiichi Sankyo INC. | $516.63 | 2019-2025 | Enhertu, Injectafer |
| Pharmacyclics LLC, An Abbvie Company | $499.74 | 2019-2023 | Imbruvica, Epkinly |
| Incyte Corporation | $490.90 | 2019-2025 | Jakafi, Monjuvi, Zynyz |
| Bayer Healthcare Pharmaceuticals INC. | $434.75 | 2019-2025 |
Show all 83 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jennifer Byer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.